Brief: Nippon Shinyaku gets marketing approval of Uptravi in EU

Nippon Shinyaku

17/05/2016 06:16

May 17 (Reuters) - Nippon Shinyaku Co Ltd  4516.T  
     
    * Says the company obtained the marketing approval of 
Uptravi in EU on May 12  
    * Says Uptravi is a medicine for the treatment of 
hypertension 
     
     
    Source text in Japanese:https://goo.gl/IRhnZ1 
    Further company coverage: 4516.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: jun.cao.reuters.com@reuters.net)) 
 
Keywords: NIPPON SHINYAKU/BRIEF